<bill session="103" type="h" number="1334" updated="2010-04-19T02:38:59-04:00">
	<state datetime="1993-03-11">REFERRED</state>
	<status><introduced datetime="1993-03-11"/></status>

	<introduced datetime="1993-03-11"/>
	<titles>
		<title type="short" as="introduced">Federal Research Product Commercialization Act</title>
		<title type="official" as="introduced">To amend the Public Health Service Act to establish a process to provide for reasonable prices for drugs, devices, and other tangible products made available to the public as a consequence of funding by the National Institutes of Health, and for other purposes.</title>
	</titles>
	<sponsor id="300100"/>
	<cosponsors>

	</cosponsors>
	<actions>
		<action datetime="1993-03-11"><text>Sponsor introductory remarks on measure. (CR E612-613)</text></action>
		<action datetime="1993-03-11"><text>Referred to the House Committee on Energy and Commerce.</text></action>
		<action datetime="1993-03-29"><committee name="House Committee on Energy and Commerce"/><text>Referred to the Subcommittee on Health and the Environment.</text></action>
		<action datetime="1993-07-23"><text>Sponsor introductory remarks on measure. (CR H5049-5050)</text></action>
	</actions>
	<committees>
		<committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee" />
		<committee code="" name="House Energy and Commerce" subcommittee="Health and Environment" activity="Referral" />
	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>
		<term name="Medical care"/>
		<term name="Administrative procedure"/>
		<term name="Biological research"/>
		<term name="Commercialization"/>
		<term name="Department of Health and Human Services"/>
		<term name="Drugs"/>
		<term name="Federal aid to medical research"/>
		<term name="Federal aid to research"/>
		<term name="Government and business"/>
		<term name="Medical economics"/>
		<term name="Medical research"/>
		<term name="Medical supplies"/>
		<term name="Pharmaceutical research"/>
		<term name="Prescription pricing"/>
		<term name="Research and development contracts"/>
		<term name="Research grants"/>
	</subjects>
	<amendments>

	</amendments>
	<summary>
	3/11/1993--Introduced.
Federal Research Product Commercialization Act - Amends the Public Health Service Act to require that a biomedical research project relating to the development of a drug, device, or other tangible product may not be supported by the National Institutes of Health (NIH) unless there is in effect an agreement ensuring that any commercial parties involved in the project make the product available to the public at a reasonable price and that the commercial parties pay NIH royalties reasonably related to the amounts NIH spent with respect to the product.

	</summary>
</bill>
